GlassScriptPhysician profile
Julie Hastings
NPI 1154736825
$3,101.63
in general payments reported to CMS, 2019-2025
17 companies · $676 in 2025
The $676 reported for 2025 was more than what 83% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $209 · 2022: $965 · 2023: $706 · 2024: $546 · 2025: $676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,928.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,927.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $620.01 | 2022-2025 | Intellis Adaptivestim, Venaseal, Inceptiv |
| Abbvie INC. | $419.78 | 2021-2025 | |
| Boston Scientific Corporation | $417.27 | 2022-2025 | Wavewriter Alpha Prime 16, Clinical Trial Product, General - Pain Management |
| Spr Therapeutics, INC | $371.53 | 2021-2025 | Sprint Pns System |
| Si-Bone, INC. | $293.48 | 2021-2024 | |
| Collegium Pharmaceutical, INC. | $245.00 | 2022-2025 | Xtampza |
| Abbott Laboratories | $192.17 | 2021-2023 | Proclaim, Eterna |
| Electronic Waveform Lab, INC. | $187.78 | 2023-2025 | |
| Ibsa Pharma INC. | $90.79 | 2024-2025 | Licart, Tirosint, Flector |
| Merz Pharmaceuticals, LLC | $68.46 | 2025 | Xeomin |
| Scilex Pharmaceuticals INC. | $40.47 | 2022-2024 | |
| Relievant Medsystems, INC. | $30.16 | 2023 | Intracept |
| Nevro Corp. | $28.58 | 2024 | Senza |
| Merck Sharp & Dohme LLC | $27.97 | 2023 | Bridion |
| Vertex Pharmaceuticals Incorporated | $24.54 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $21.88 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Nalu Medical, INC. | $21.76 | 2024 | Nalu Neurostimulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Hastings listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.